dichloroacetic acid has been researched along with Carcinoma, Epidermoid in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agriesti, F; Capitanio, N; Laurenzana, I; Lo Muzio, L; Mazzoccoli, C; Perrone, D; Piccoli, C; Ruggieri, V; Scrima, R; Tataranni, T | 1 |
| Fan, Z; Li, X; Lu, H; Lu, Y; Qiu, S | 1 |
| Bol, A; Brender, JR; De Preter, G; Feron, O; Gallez, B; Grégoire, V; Jordan, BF; Joudiou, N; Kishimoto, S; Krishna, MC; Neveu, MA; Saito, K | 1 |
| Menn, H; Tomsick, RS | 1 |
4 other study(ies) available for dichloroacetic acid and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Dichloroacetate, a selective mitochondria-targeting drug for oral squamous cell carcinoma: a metabolic perspective of treatment.
Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Dichloroacetic Acid; Glycolysis; Humans; Immunoblotting; Membrane Potential, Mitochondrial; Mitochondria; Mouth Neoplasms; NAD; Oxidation-Reduction; Oxidative Phosphorylation; Phosphorylation; Pyruvate Dehydrogenase (Lipoamide) | 2015 |
ASCT2 (SLC1A5) is an EGFR-associated protein that can be co-targeted by cetuximab to sensitize cancer cells to ROS-induced apoptosis.
Topics: Amino Acid Transport System ASC; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cetuximab; Dichloroacetic Acid; Down-Regulation; Endocytosis; ErbB Receptors; Gefitinib; Glutamine; Glutathione; Head and Neck Neoplasms; Humans; Minor Histocompatibility Antigens; Oxidative Stress; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Quinazolines; Reactive Oxygen Species; RNA Interference; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; Time Factors; Transfection | 2016 |
Multi-modality imaging to assess metabolic response to dichloroacetate treatment in tumor models.
Topics: Antineoplastic Agents; Breast Neoplasms; Carbon-13 Magnetic Resonance Spectroscopy; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Dichloroacetic Acid; Energy Metabolism; Enzyme Inhibitors; Female; Glycolysis; Humans; Lactic Acid; Magnetic Resonance Imaging; Oxidation-Reduction; Oxygen Consumption; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Protein Serine-Threonine Kinases; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Pyruvic Acid; Time Factors; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2016 |
Squamous cell carcinoma of the fingers treated with chemosurgery.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chlorides; Curettage; Dichloroacetic Acid; Female; Fingers; Follow-Up Studies; Humans; Male; Methods; Middle Aged; Nails; Skin Neoplasms; Zinc; Zinc Compounds | 1984 |